CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenues:
Obstructive sleep apnea (OSA)	$ 169,944	$ 209,572	$ 350,567	$ 335,692
Total revenues	169,944	209,572	350,567	335,692
Costs and expenses:
Cost of revenues	185,245	70,141	234,344	123,031
General and administrative	513,012	699,878	987,059	1,098,404
Depreciation	150		300
Total costs and expenses	698,407	770,019	1,221,703	1,221,435
Loss from operations	(528,463)	(560,447)	(871,136)	(885,743)
Other income (expense):
Interest expense	(408,747)	(361,021)	(840,873)	(724,542)
Legal settlement	328,269	(17,031)	328,269	(17,031)
Settlement of prior accounting services			(240,000)
Extinguishment of loan due to shareholder	7,771,140		7,771,140
Other income			2,380
Total other income (expense)	7,690,662	(378,052)	7,020,916	(741,573)
Income taxes
Net income (loss)	$ 7,162,199	$ (938,499)	$ 6,149,780	$ (1,627,316)
PER SHARE INFORMATION
Net Income (Loss) Per Common Share (in dollars per share)	$ 0.11	$ (0.01)	$ 0.09	$ (0.03)
Weighted Average Number of Common Shares Outstanding (in shares)	66,573,855	63,063,685	65,436,202	63,063,685